Danaher | DHR - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Abbott USD 5.86B 675M 2026-03
Agilent USD 990M 44M 2026-03
Align Technology USD 736.59M 53M 2026-03
Becton, Dickinson and Co. USD 2.15B 257M 2026-03
Bio Techne USD 208.29M 17.01M 2026-03
Bio-Rad Laboratories USD 345.2M 1.8M 2025-12
Boston Scientific USD 3.61B 64M 2026-03
Bruker USD 379.8M 69.4M 2026-03
Charles River Laboratories USD 279.32M 7.36M 2026-03
Danaher USD 3.59B 375M 2026-03
Dentsply International USD 427M 16M 2026-03
Edwards Lifesciences USD 1.29B 59.4M 2026-03
ESCO Technologies USD 99.6M 49.54M 2025-12
Fortive USD 675.5M 33.4M 2026-03
Henry Schein USD 1.07B 7M 2026-03
Illumina USD 721M 38M 2026-03
Intuitive Surgical USD 1.83B 73.8M 2026-03
IQVIA Holdings USD 1.07B 52M 2026-03
Keysight Technologies USD 1.18B 183M 2026-03
Laboratory Of America USD 1.01B 20.6M 2026-03
Medtronic USD 6.01B 595M 2026-03
Mettler Toledo International USD 675.44M 65.98M 2025-12
Myriad Genetics USD 146.8M 3M 2025-12
OraSure Technologies USD 11.34M 435K 2025-12
Quest Diagnostics USD 906M 33M 2026-03
Quidel USD -91.8M 366.6M 2026-03
Repligen USD 108.28M 4.45M 2026-03
Revvity USD 387.66M 34M 2026-03
Roper Industries USD 1.43B 26.9M 2025-12
Stryker USD 3.81B 675M 2026-03
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Waters USD 542M 15.42M 2026-03
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12